Tetravalent influenza vaccines generating an antibody immune response mostly directed against the highly drifting hemagglutinin (HA) and neuraminidase (NA) envelope glycoproteins of the virus are the cornerstone of today’s influenza prevention (2). The gene discussed is ERVW-1; the disease is influenza.